ID   GALT2_HUMAN             Reviewed;         571 AA.
AC   Q10471; A8K1Y3; B7Z8V8; C5HU00; Q9NPY4;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-MAR-2017, entry version 161.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 2;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 2;
DE            Short=GalNAc-T2;
DE            Short=pp-GaNTase 2;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 2;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2;
DE   Contains:
DE     RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 2 soluble form;
GN   Name=GALNT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 52-93;
RP   104-120; 170-182; 193-218; 303-323; 421-424 AND 510-546, FUNCTION,
RP   COFACTOR, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Gastric carcinoma;
RX   PubMed=7592619; DOI=10.1074/jbc.270.41.24166;
RA   White T., Bennett E.P., Takio K., Soerensen T., Bonding N.,
RA   Clausen H.;
RT   "Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-
RT   galactosamine:polypeptide N-acetylgalactosaminyltransferase.";
RL   J. Biol. Chem. 270:24156-24165(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-554.
RC   TISSUE=Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=9295285; DOI=10.1074/jbc.272.38.23503;
RA   Wandall H.H., Hassan H., Mirgorodskaya E., Kristensen A.K.,
RA   Roepstorff P., Bennett E.P., Nielsen P.A., Hollingsworth M.A.,
RA   Burchell J., Taylor-Papadimitriou J., Clausen H.;
RT   "Substrate specificities of three members of the human UDP-N-acetyl-
RT   alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase
RT   family, GalNAc-T1, -T2, and -T3.";
RL   J. Biol. Chem. 272:23503-23514(1997).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9394011;
RA   Roettger S., White J., Wandall H.H., Olivo J.-C., Stark A.,
RA   Bennett E.P., Whitehouse C., Berger E.G., Clausen H., Nilsson T.;
RT   "Localization of three human polypeptide GalNAc-transferases in HeLa
RT   cells suggests initiation of O-linked glycosylation throughout the
RT   Golgi apparatus.";
RL   J. Cell Sci. 111:45-60(1998).
RN   [9]
RP   FUNCTION.
RX   PubMed=12438318; DOI=10.1074/jbc.M211097200;
RA   Iwasaki H., Zhang Y., Tachibana K., Gotoh M., Kikuchi N., Kwon Y.-D.,
RA   Togayachi A., Kudo T., Kubota T., Narimatsu H.;
RT   "Initiation of O-glycan synthesis in IgA1 hinge region is determined
RT   by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
RT   acetylgalactosaminyltransferase 2.";
RL   J. Biol. Chem. 278:5613-5621(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-536, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 75-571 IN COMPLEX WITH UDP;
RP   PEPTIDE SUBSTRATE AND MANGANESE, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, AND DISULFIDE BONDS.
RX   PubMed=16434399; DOI=10.1074/jbc.M513590200;
RA   Fritz T.A., Raman J., Tabak L.A.;
RT   "Dynamic association between the catalytic and lectin domains of human
RT   UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2.";
RL   J. Biol. Chem. 281:8613-8619(2006).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. Has a broad spectrum of substrates for peptides
CC       such as EA2, Muc5AC, Muc1a, Muc1b. Probably involved in O-linked
CC       glycosylation of the immunoglobulin A1 (IgA1) hinge region.
CC       {ECO:0000269|PubMed:12438318, ECO:0000269|PubMed:16434399,
CC       ECO:0000269|PubMed:7592619, ECO:0000269|PubMed:9295285}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:16434399, ECO:0000269|PubMed:7592619}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:16434399,
CC         ECO:0000269|PubMed:7592619};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- INTERACTION:
CC       Q8N6L0:CCDC155; NbExp=5; IntAct=EBI-10226985, EBI-749265;
CC       Q9HC29:NOD2; NbExp=2; IntAct=EBI-10226985, EBI-7445625;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
CC       {ECO:0000269|PubMed:9394011}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:9394011}. Secreted
CC       {ECO:0000269|PubMed:9394011}. Note=Resides preferentially in the
CC       trans and medial parts of the Golgi stack. A secreted form also
CC       exists.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q10471-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q10471-2; Sequence=VSP_056491, VSP_056492, VSP_056493;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:7592619}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 2;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_484";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85019; CAA59381.1; -; mRNA.
DR   EMBL; AK290048; BAF82737.1; -; mRNA.
DR   EMBL; AK304029; BAH14094.1; -; mRNA.
DR   EMBL; AL592228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL078646; CAC00585.2; -; Genomic_DNA.
DR   EMBL; AL117349; CAC00585.2; JOINED; Genomic_DNA.
DR   EMBL; AL136988; CAC00585.2; JOINED; Genomic_DNA.
DR   EMBL; AL117349; CAI22902.1; -; Genomic_DNA.
DR   EMBL; AL078646; CAI22902.1; JOINED; Genomic_DNA.
DR   EMBL; AL136988; CAI22902.1; JOINED; Genomic_DNA.
DR   EMBL; AL136988; CAI23447.1; -; Genomic_DNA.
DR   EMBL; AL078646; CAI23447.1; JOINED; Genomic_DNA.
DR   EMBL; AL117349; CAI23447.1; JOINED; Genomic_DNA.
DR   EMBL; FJ515852; ACS13744.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW69911.1; -; Genomic_DNA.
DR   EMBL; BC041120; AAH41120.1; -; mRNA.
DR   CCDS; CCDS1582.1; -. [Q10471-1]
DR   PIR; I37405; I37405.
DR   RefSeq; NP_001278795.1; NM_001291866.1.
DR   RefSeq; NP_004472.1; NM_004481.4. [Q10471-1]
DR   UniGene; Hs.743964; -.
DR   PDB; 2FFU; X-ray; 1.64 A; A=75-571.
DR   PDB; 2FFV; X-ray; 2.75 A; A/B=75-571.
DR   PDB; 4D0T; X-ray; 2.45 A; A/B/C/D/E/F=1-571.
DR   PDB; 4D0Z; X-ray; 2.20 A; A/B/C/D/E/F=1-571.
DR   PDB; 4D11; X-ray; 2.85 A; A/B/C/D/E/F=1-571.
DR   PDB; 5AJN; X-ray; 1.67 A; A=1-571.
DR   PDB; 5AJO; X-ray; 1.48 A; A=1-571.
DR   PDB; 5AJP; X-ray; 1.65 A; A=1-571.
DR   PDB; 5FV9; X-ray; 2.07 A; A/B/C/D/E/F=1-571.
DR   PDBsum; 2FFU; -.
DR   PDBsum; 2FFV; -.
DR   PDBsum; 4D0T; -.
DR   PDBsum; 4D0Z; -.
DR   PDBsum; 4D11; -.
DR   PDBsum; 5AJN; -.
DR   PDBsum; 5AJO; -.
DR   PDBsum; 5AJP; -.
DR   PDBsum; 5FV9; -.
DR   ProteinModelPortal; Q10471; -.
DR   SMR; Q10471; -.
DR   BioGrid; 108862; 26.
DR   IntAct; Q10471; 18.
DR   MINT; MINT-3026412; -.
DR   STRING; 9606.ENSP00000355632; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q10471; -.
DR   PhosphoSitePlus; Q10471; -.
DR   SwissPalm; Q10471; -.
DR   BioMuta; GALNT2; -.
DR   DMDM; 51315838; -.
DR   EPD; Q10471; -.
DR   MaxQB; Q10471; -.
DR   PaxDb; Q10471; -.
DR   PeptideAtlas; Q10471; -.
DR   PRIDE; Q10471; -.
DR   DNASU; 2590; -.
DR   Ensembl; ENST00000366672; ENSP00000355632; ENSG00000143641. [Q10471-1]
DR   GeneID; 2590; -.
DR   KEGG; hsa:2590; -.
DR   UCSC; uc010pwa.2; human. [Q10471-1]
DR   CTD; 2590; -.
DR   DisGeNET; 2590; -.
DR   GeneCards; GALNT2; -.
DR   H-InvDB; HIX0001682; -.
DR   HGNC; HGNC:4124; GALNT2.
DR   HPA; HPA011222; -.
DR   MIM; 602274; gene.
DR   neXtProt; NX_Q10471; -.
DR   OpenTargets; ENSG00000143641; -.
DR   PharmGKB; PA28537; -.
DR   eggNOG; KOG3738; Eukaryota.
DR   eggNOG; ENOG410XPRX; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOGENOM; HOG000038227; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q10471; -.
DR   KO; K00710; -.
DR   OMA; GKVRWPD; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q10471; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT2; human.
DR   EvolutionaryTrace; Q10471; -.
DR   GeneWiki; GALNT2; -.
DR   GenomeRNAi; 2590; -.
DR   PRO; PR:Q10471; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143641; -.
DR   CleanEx; HS_GALNT2; -.
DR   Genevisible; Q10471; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005795; C:Golgi stack; IDA:BHF-UCL.
DR   GO; GO:0030173; C:integral component of Golgi membrane; NAS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0002378; P:immunoglobulin biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0016266; P:O-glycan processing; IDA:GO_Central.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; IDA:BHF-UCL.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IDA:BHF-UCL.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycosyltransferase;
KW   Golgi apparatus; Lectin; Manganese; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Secreted;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    571       Polypeptide N-
FT                                acetylgalactosaminyltransferase 2.
FT                                /FTId=PRO_0000223391.
FT   CHAIN        52    571       Polypeptide N-
FT                                acetylgalactosaminyltransferase 2 soluble
FT                                form.
FT                                /FTId=PRO_0000012265.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     24       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     25    571       Lumenal. {ECO:0000255}.
FT   DOMAIN      443    566       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      135    240       Catalytic subdomain A.
FT   REGION      300    362       Catalytic subdomain B.
FT   METAL       224    224       Manganese. {ECO:0000269|PubMed:16434399}.
FT   METAL       226    226       Manganese. {ECO:0000269|PubMed:16434399}.
FT   METAL       359    359       Manganese. {ECO:0000269|PubMed:16434399}.
FT   BINDING     143    143       Substrate.
FT   BINDING     176    176       Substrate.
FT   BINDING     201    201       Substrate.
FT   BINDING     225    225       Substrate.
FT   BINDING     331    331       Substrate.
FT   BINDING     362    362       Substrate.
FT   BINDING     365    365       Substrate.
FT   BINDING     367    367       Substrate.
FT   SITE        516    516       Not glycosylated.
FT   MOD_RES     536    536       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   DISULFID    126    354       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16434399}.
FT   DISULFID    345    423       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16434399}.
FT   DISULFID    456    473       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16434399}.
FT   DISULFID    496    513       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16434399}.
FT   DISULFID    539    555       {ECO:0000255|PROSITE-ProRule:PRU00174,
FT                                ECO:0000269|PubMed:16434399}.
FT   VAR_SEQ       1     90       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056491.
FT   VAR_SEQ     303    355       TPMIAGGLFVMDKFYFEELGKYDMMMDVWGGENLEISFRVW
FT                                QCGGSLEIIPCS -> DLVPRVAVWWQPGDHPVQPCGTRVP
FT                                EAAPLHVPGWQWHCLCPKHPPGSRGLDG (in isoform
FT                                2). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056492.
FT   VAR_SEQ     356    571       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056493.
FT   VARIANT     245    245       R -> H (in dbSNP:rs1923950).
FT                                /FTId=VAR_049240.
FT   VARIANT     554    554       V -> M (in dbSNP:rs2273970).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_019575.
FT   CONFLICT     70     70       T -> G (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       W -> D (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     93     93       R -> G (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       R -> W (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    290    291       RR -> SC (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       R -> Q (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       P -> H (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    522    522       W -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    533    533       H -> M (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        78     80       {ECO:0000244|PDB:5AJO}.
FT   HELIX        83     87       {ECO:0000244|PDB:5AJO}.
FT   HELIX        88     90       {ECO:0000244|PDB:5AJO}.
FT   TURN         98    102       {ECO:0000244|PDB:5AJO}.
FT   HELIX       106    111       {ECO:0000244|PDB:5AJO}.
FT   HELIX       124    128       {ECO:0000244|PDB:5AJO}.
FT   STRAND      138    146       {ECO:0000244|PDB:5AJO}.
FT   HELIX       149    162       {ECO:0000244|PDB:5AJO}.
FT   HELIX       165    167       {ECO:0000244|PDB:5AJO}.
FT   STRAND      168    175       {ECO:0000244|PDB:5AJO}.
FT   HELIX       182    185       {ECO:0000244|PDB:5AJO}.
FT   HELIX       186    189       {ECO:0000244|PDB:5AJO}.
FT   STRAND      193    197       {ECO:0000244|PDB:5AJO}.
FT   HELIX       204    214       {ECO:0000244|PDB:5AJO}.
FT   STRAND      217    223       {ECO:0000244|PDB:5AJO}.
FT   STRAND      225    229       {ECO:0000244|PDB:5AJO}.
FT   HELIX       235    243       {ECO:0000244|PDB:5AJO}.
FT   STRAND      247    256       {ECO:0000244|PDB:5AJO}.
FT   TURN        258    260       {ECO:0000244|PDB:5AJO}.
FT   STRAND      270    274       {ECO:0000244|PDB:5AJO}.
FT   STRAND      280    284       {ECO:0000244|PDB:5AJO}.
FT   HELIX       287    295       {ECO:0000244|PDB:5AJO}.
FT   STRAND      308    314       {ECO:0000244|PDB:5AJO}.
FT   HELIX       315    320       {ECO:0000244|PDB:5AJO}.
FT   STRAND      330    332       {ECO:0000244|PDB:5AJO}.
FT   HELIX       336    344       {ECO:0000244|PDB:5AJO}.
FT   STRAND      348    360       {ECO:0000244|PDB:5AJO}.
FT   STRAND      363    365       {ECO:0000244|PDB:5AJO}.
FT   TURN        366    368       {ECO:0000244|PDB:2FFV}.
FT   STRAND      369    371       {ECO:0000244|PDB:5AJO}.
FT   HELIX       373    376       {ECO:0000244|PDB:5AJO}.
FT   HELIX       378    388       {ECO:0000244|PDB:5AJO}.
FT   HELIX       390    392       {ECO:0000244|PDB:5AJO}.
FT   HELIX       393    399       {ECO:0000244|PDB:5AJO}.
FT   HELIX       401    403       {ECO:0000244|PDB:5AJO}.
FT   HELIX       412    420       {ECO:0000244|PDB:5AJO}.
FT   HELIX       426    432       {ECO:0000244|PDB:5AJO}.
FT   STRAND      445    452       {ECO:0000244|PDB:5AJO}.
FT   STRAND      455    458       {ECO:0000244|PDB:5AJO}.
FT   TURN        463    465       {ECO:0000244|PDB:2FFV}.
FT   STRAND      469    472       {ECO:0000244|PDB:5AJO}.
FT   HELIX       478    480       {ECO:0000244|PDB:5AJO}.
FT   STRAND      482    484       {ECO:0000244|PDB:5AJO}.
FT   STRAND      490    492       {ECO:0000244|PDB:5AJO}.
FT   STRAND      495    498       {ECO:0000244|PDB:5AJO}.
FT   STRAND      509    512       {ECO:0000244|PDB:5AJO}.
FT   HELIX       518    520       {ECO:0000244|PDB:5AJO}.
FT   STRAND      522    525       {ECO:0000244|PDB:5AJO}.
FT   TURN        526    529       {ECO:0000244|PDB:5AJO}.
FT   STRAND      530    533       {ECO:0000244|PDB:5AJO}.
FT   STRAND      536    541       {ECO:0000244|PDB:5AJO}.
FT   HELIX       545    547       {ECO:0000244|PDB:5AJO}.
FT   STRAND      551    554       {ECO:0000244|PDB:5AJO}.
FT   HELIX       559    561       {ECO:0000244|PDB:5AJO}.
FT   STRAND      564    568       {ECO:0000244|PDB:5AJO}.
SQ   SEQUENCE   571 AA;  64733 MW;  D9A0F5D17C55BAF2 CRC64;
     MRRRSRMLLC FAFLWVLGIA YYMYSGGGSA LAGGAGGGAG RKEDWNEIDP IKKKDLHHSN
     GEEKAQSMET LPPGKVRWPD FNQEAYVGGT MVRSGQDPYA RNKFNQVESD KLRMDRAIPD
     TRHDQCQRKQ WRVDLPATSV VITFHNEARS ALLRTVVSVL KKSPPHLIKE IILVDDYSND
     PEDGALLGKI EKVRVLRNDR REGLMRSRVR GADAAQAKVL TFLDSHCECN EHWLEPLLER
     VAEDRTRVVS PIIDVINMDN FQYVGASADL KGGFDWNLVF KWDYMTPEQR RSRQGNPVAP
     IKTPMIAGGL FVMDKFYFEE LGKYDMMMDV WGGENLEISF RVWQCGGSLE IIPCSRVGHV
     FRKQHPYTFP GGSGTVFARN TRRAAEVWMD EYKNFYYAAV PSARNVPYGN IQSRLELRKK
     LSCKPFKWYL ENVYPELRVP DHQDIAFGAL QQGTNCLDTL GHFADGVVGV YECHNAGGNQ
     EWALTKEKSV KHMDLCLTVV DRAPGSLIKL QGCRENDSRQ KWEQIEGNSK LRHVGSNLCL
     DSRTAKSGGL SVEVCGPALS QQWKFTLNLQ Q
//
